Cambium Bio Ltd (CMB) - Cash Flow Conversion Efficiency

Latest as of June 2025: -1.444x

Based on the latest financial reports, Cambium Bio Ltd (CMB) has a cash flow conversion efficiency ratio of -1.444x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.65 Million ≈ $-1.88 Million USD) by net assets (AU$1.84 Million ≈ $1.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Cambium Bio Ltd to measure how many days the company can operate on defensive assets alone.

Cambium Bio Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Cambium Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cambium Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cambium Bio Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SEKUR PRIVATE DATA LTD. F:GDT0	-0.702x
Akkhie Prakarn Public Company Limited BK:AKP	0.036x
Phoenix Motor Inc. Common Stock NASDAQ:PEV	-0.277x
Pets at Home Group Plc LSE:PETS	0.086x
Ep&T Global Ltd AU:EPX	-0.485x
Resources & Energy Group Ltd AU:REZ	-0.115x
Reabold Resources Plc LSE:RBD	-0.032x
Fiberweb (India) Limited NSE:FIBERWEB	0.085x

Annual Cash Flow Conversion Efficiency for Cambium Bio Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Cambium Bio Ltd from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Cambium Bio Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.84 Million ≈ $1.30 Million	AU$-5.24 Million ≈ $-3.71 Million	-2.856x	-4986.40%
2024-06-30	AU$2.78 Million ≈ $1.96 Million	AU$-155.86K ≈ $-110.28K	-0.056x	-116.58%
2023-06-30	AU$-1.95 Million ≈ $-1.38 Million	AU$-660.46K ≈ $-467.32K	0.339x	+110.13%
2022-06-30	AU$1.07 Million ≈ $760.48K	AU$-3.59 Million ≈ $-2.54 Million	-3.341x	-672.70%
2021-06-30	AU$4.15 Million ≈ $2.93 Million	AU$2.42 Million ≈ $1.71 Million	0.583x	+132.85%
2020-06-30	AU$1.09 Million ≈ $774.10K	AU$-1.94 Million ≈ $-1.37 Million	-1.776x	-414.34%
2019-06-30	AU$-6.39 Million ≈ $-4.52 Million	AU$-3.61 Million ≈ $-2.55 Million	0.565x	+138.87%
2018-06-30	AU$2.92 Million ≈ $2.07 Million	AU$-4.25 Million ≈ $-3.01 Million	-1.454x	-428.22%
2017-06-30	AU$8.10 Million ≈ $5.73 Million	AU$3.59 Million ≈ $2.54 Million	0.443x	+194.04%
2016-06-30	AU$4.78 Million ≈ $3.39 Million	AU$-2.25 Million ≈ $-1.59 Million	-0.471x	+34.23%
2015-06-30	AU$8.27 Million ≈ $5.85 Million	AU$-5.92 Million ≈ $-4.19 Million	-0.716x	+4.65%
2014-06-30	AU$8.31 Million ≈ $5.88 Million	AU$-6.24 Million ≈ $-4.41 Million	-0.751x	-146.66%
2013-06-30	AU$-2.87 Million ≈ $-2.03 Million	AU$-4.62 Million ≈ $-3.27 Million	1.610x	+206.69%
2012-06-30	AU$1.95 Million ≈ $1.38 Million	AU$-2.94 Million ≈ $-2.08 Million	-1.509x	-372.04%
2011-06-30	AU$3.29 Million ≈ $2.33 Million	AU$-1.05 Million ≈ $-743.44K	-0.320x	-338.79%
2002-06-30	AU$40.54 Million ≈ $28.68 Million	AU$5.43 Million ≈ $3.84 Million	0.134x	-31.25%
2001-06-30	AU$196.21 Million ≈ $138.83 Million	AU$38.20 Million ≈ $27.03 Million	0.195x	-35.02%
2000-06-30	AU$161.09 Million ≈ $113.98 Million	AU$48.26 Million ≈ $34.15 Million	0.300x	+17.02%
1999-06-30	AU$130.56 Million ≈ $92.38 Million	AU$33.43 Million ≈ $23.65 Million	0.256x	--

About Cambium Bio Ltd

AU:CMB Australia Biotechnology

Market Cap

$9.19 Million

AU$12.98 Million AUD

Market Cap Rank

#27255 Global

#1353 in Australia

Share Price

AU$0.48

Change (1 day)

+14.46%

52-Week Range

AU$0.20 - AU$0.60

All Time High

AU$22.97